Overview
Zhen-sheng Yue practices practicing medicine in Xi'an, China.
Their clinical expertise encompasses Nonalcoholic Steatohepatitis (NASH), Non-Alcoholic Fatty Liver Disease, Diabetic Retinopathy, and Cirrhosis.
They are actively involved in clinical research, co-authoring 11 peer reviewed articles.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Zhen-sheng Yue
Is Zhen-sheng Yue a top-rated expert for Nonalcoholic Steatohepatitis (NASH)?
MediFind is an objective health platform that identifies experts based on real-world data. Zhen-sheng Yue is classified as an Experienced expert for Nonalcoholic Steatohepatitis (NASH), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Zhen-sheng Yue participate in research or clinical trials?
Yes. Zhen-sheng Yue has published 11 articles and abstracts on conditions like Nonalcoholic Steatohepatitis (NASH). You can view a list of Zhen-sheng Yue's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- CirrhosisYue isExperienced. Learn about Cirrhosis.
- Diabetic RetinopathyYue isExperienced. Learn about Diabetic Retinopathy.
- Non-Alcoholic Fatty Liver Disease
- Nonalcoholic Steatohepatitis (NASH)